Skip to main content
Erschienen in: Archives of Virology 2/2022

20.01.2022 | Brief Report

Complete genome sequencing and evolutionary analysis of hepatitis C virus subtype 6a, including strains from Guangdong Province, China

verfasst von: Ru Xu, Hao Wang, Jieting Huang, Min Wang, Qiao Liao, Zhengang Shan, Huishan Zhong, Xia Rong, Yongshui Fu

Erschienen in: Archives of Virology | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

We performed an evolutionary analysis using whole genome sequence isolates of hepatitis C virus (HCV) 6a from Guangdong Province and reference sequences from various countries. Less than 5% of the HCV genome was found to be under positive selection. The E1 and E2 proteins had the highest proportion of positively selected sites both within and outside of CD8 T cell epitopes in all of the strains. Regions corresponding to CD8 T cell epitopes were under negative selection except in the isolates from Guangdong. Furthermore, we found evidence of three introductions of the virus into Guangdong from Vietnam and other Southeast Asian countries. Thus, this study provides information about the transmission of HCV 6a by comparison of full-length sequences, indicating the impact of selective constraints in Guangdong and across China.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Dunford L, Carr MJ, Dean J et al (2012) Hepatitis C virus in Vietnam: high prevalence of infection in dialysis and multi-transfused patients involving diverse and novel virus variants. PLoS ONE 7:e41266CrossRef Dunford L, Carr MJ, Dean J et al (2012) Hepatitis C virus in Vietnam: high prevalence of infection in dialysis and multi-transfused patients involving diverse and novel virus variants. PLoS ONE 7:e41266CrossRef
2.
Zurück zum Zitat Chen Y, Yu C, Yin X et al (2017) Hepatitis C virus genotypes and subtypes circulating in Mainland China. Emerg Microbes Infect. 6:e95PubMedPubMedCentral Chen Y, Yu C, Yin X et al (2017) Hepatitis C virus genotypes and subtypes circulating in Mainland China. Emerg Microbes Infect. 6:e95PubMedPubMedCentral
3.
Zurück zum Zitat Thong VD, Akkarathamrongsin S, Poovorawan K et al (2014) Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implication. World J Gastroenterol 20:2927–2940CrossRef Thong VD, Akkarathamrongsin S, Poovorawan K et al (2014) Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implication. World J Gastroenterol 20:2927–2940CrossRef
4.
Zurück zum Zitat Wang M, Liao Q, Xu R et al (2019) Hepatitis C virus 3b strains in injection drug users in Guangdong Province, China, may have originated in Yunnan Province. Arch Virol 164:1761–1770CrossRef Wang M, Liao Q, Xu R et al (2019) Hepatitis C virus 3b strains in injection drug users in Guangdong Province, China, may have originated in Yunnan Province. Arch Virol 164:1761–1770CrossRef
5.
Zurück zum Zitat Rong X, Xu R, Xiong H et al (2014) Increased prevalence of hepatitis C virus subtype 6a in China: a comparison between 2004–2007 and 2008–2011. Arch Virol 159:3231–3237CrossRef Rong X, Xu R, Xiong H et al (2014) Increased prevalence of hepatitis C virus subtype 6a in China: a comparison between 2004–2007 and 2008–2011. Arch Virol 159:3231–3237CrossRef
6.
Zurück zum Zitat Li Q, Yao Y, Shen Y et al (2017) Assessment of HCV genotypes in Yunnan Province of Southwest China. Virus Genes 53:190–196CrossRef Li Q, Yao Y, Shen Y et al (2017) Assessment of HCV genotypes in Yunnan Province of Southwest China. Virus Genes 53:190–196CrossRef
7.
Zurück zum Zitat Bull RA, Luciani F, McElroy K et al (2011) Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection. PLoS Pathog 7:e1002243CrossRef Bull RA, Luciani F, McElroy K et al (2011) Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection. PLoS Pathog 7:e1002243CrossRef
8.
Zurück zum Zitat Cuevas JM, Gonzalez M, Torres-Puente M et al (2009) The role of positive selection in hepatitis C virus. Infect Genet Evol 9:860–866CrossRef Cuevas JM, Gonzalez M, Torres-Puente M et al (2009) The role of positive selection in hepatitis C virus. Infect Genet Evol 9:860–866CrossRef
9.
Zurück zum Zitat Yuan M, Lu T, Li C et al (2013) The evolutionary rates of HCV estimated with subtype 1a and 1b sequences over the ORF length and in different genomic regions. PLoS ONE 8:e64698CrossRef Yuan M, Lu T, Li C et al (2013) The evolutionary rates of HCV estimated with subtype 1a and 1b sequences over the ORF length and in different genomic regions. PLoS ONE 8:e64698CrossRef
10.
Zurück zum Zitat Xu R, Huang JT, Du RS et al (2020) High-throughput next generation sequencing technology for the comprehensive assessment of full-length hepatitis C viral genomes in IDU population of Guangdong province. Chin J Blood Transfus 33:565–568 (article in Chinese) Xu R, Huang JT, Du RS et al (2020) High-throughput next generation sequencing technology for the comprehensive assessment of full-length hepatitis C viral genomes in IDU population of Guangdong province. Chin J Blood Transfus 33:565–568 (article in Chinese)
11.
Zurück zum Zitat Martin DP, Murrell B, Golden M et al (2015) RDP4: Detection and analysis of recombination patterns in virus genomes. Virus Evol. 1:vev003CrossRef Martin DP, Murrell B, Golden M et al (2015) RDP4: Detection and analysis of recombination patterns in virus genomes. Virus Evol. 1:vev003CrossRef
12.
Zurück zum Zitat Kosakovsky Pond SL, Posada D, Gravenor MB et al (2006) GARD: a genetic algorithm for recombination detection. Bioinformatics 22:3096–3098CrossRef Kosakovsky Pond SL, Posada D, Gravenor MB et al (2006) GARD: a genetic algorithm for recombination detection. Bioinformatics 22:3096–3098CrossRef
13.
Zurück zum Zitat Huang K, Chen J, Xu R et al (2018) Molecular evolution of hepatitis C virus in China: a nationwide study. Virology 516:210–218CrossRef Huang K, Chen J, Xu R et al (2018) Molecular evolution of hepatitis C virus in China: a nationwide study. Virology 516:210–218CrossRef
14.
Zurück zum Zitat Pybus OG, Barnes E, Taggart R et al (2009) Genetic history of hepatitis C virus in East Asia. J Virol 83:1071–1082CrossRef Pybus OG, Barnes E, Taggart R et al (2009) Genetic history of hepatitis C virus in East Asia. J Virol 83:1071–1082CrossRef
15.
Zurück zum Zitat Pham VH, Nguyen HD, Ho PT et al (2011) Very high prevalence of hepatitis C virus genotype 6 variants in southern Vietnam: large-scale survey based on sequence determination. Jpn J Infect Dis 64:537–539PubMedPubMedCentral Pham VH, Nguyen HD, Ho PT et al (2011) Very high prevalence of hepatitis C virus genotype 6 variants in southern Vietnam: large-scale survey based on sequence determination. Jpn J Infect Dis 64:537–539PubMedPubMedCentral
16.
Zurück zum Zitat Fu Y, Qin W, Cao H et al (2012) HCV 6a prevalence in Guangdong province had the origin from Vietnam and recent dissemination to other regions of China: phylogeographic analyses. PLoS ONE 7:e28006CrossRef Fu Y, Qin W, Cao H et al (2012) HCV 6a prevalence in Guangdong province had the origin from Vietnam and recent dissemination to other regions of China: phylogeographic analyses. PLoS ONE 7:e28006CrossRef
17.
Zurück zum Zitat McCormick AL, Macartney MJ, Abdi-Abshir I et al (2015) Evaluation of sequencing of HCV core/E1, NS5A and NS5B as a genotype predictive tool in comparison with commercial assays targeting 5’UTR. J Clin Virol 66:56–59CrossRef McCormick AL, Macartney MJ, Abdi-Abshir I et al (2015) Evaluation of sequencing of HCV core/E1, NS5A and NS5B as a genotype predictive tool in comparison with commercial assays targeting 5’UTR. J Clin Virol 66:56–59CrossRef
18.
Zurück zum Zitat Patino-Galindo JA, Gonzalez-Candelas F (2017) Comparative analysis of variation and selection in the HCV genome. Infect Genet Evol 49:104–110CrossRef Patino-Galindo JA, Gonzalez-Candelas F (2017) Comparative analysis of variation and selection in the HCV genome. Infect Genet Evol 49:104–110CrossRef
19.
Zurück zum Zitat Hanada K, Gojobori T, Li WH (2006) Radical amino acid change versus positive selection in the evolution of viral envelope proteins. Gene 385:83–88CrossRef Hanada K, Gojobori T, Li WH (2006) Radical amino acid change versus positive selection in the evolution of viral envelope proteins. Gene 385:83–88CrossRef
20.
Zurück zum Zitat Cuypers L, Li G, Libin P et al (2015) Genetic Diversity and Selective Pressure in Hepatitis C Virus Genotypes 1–6: Significance for Direct-Acting Antiviral Treatment and Drug Resistance. Viruses 7:5018–5039CrossRef Cuypers L, Li G, Libin P et al (2015) Genetic Diversity and Selective Pressure in Hepatitis C Virus Genotypes 1–6: Significance for Direct-Acting Antiviral Treatment and Drug Resistance. Viruses 7:5018–5039CrossRef
21.
Zurück zum Zitat Forni D, Cagliani R, Pontremoli C et al (2018) Evolutionary analysis provides insight into the origin and adaptation of HCV. Front Microbiol 9:854CrossRef Forni D, Cagliani R, Pontremoli C et al (2018) Evolutionary analysis provides insight into the origin and adaptation of HCV. Front Microbiol 9:854CrossRef
22.
Zurück zum Zitat Wu R, Geng D, Chi X et al (2019) Computational analysis of naturally occurring resistance-associated substitutions in genes NS3, NS5A, and NS5B among 86 subtypes of hepatitis C virus worldwide. Infect Drug Resist. 12:2987–3015CrossRef Wu R, Geng D, Chi X et al (2019) Computational analysis of naturally occurring resistance-associated substitutions in genes NS3, NS5A, and NS5B among 86 subtypes of hepatitis C virus worldwide. Infect Drug Resist. 12:2987–3015CrossRef
23.
Zurück zum Zitat Schulze Zur Wiesch J, Ciuffreda D, Lewis-Ximenez L et al (2012) Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence. J Exp Med 209:61–75CrossRef Schulze Zur Wiesch J, Ciuffreda D, Lewis-Ximenez L et al (2012) Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence. J Exp Med 209:61–75CrossRef
24.
Zurück zum Zitat Fitzmaurice K, Petrovic D, Ramamurthy N et al (2011) Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection. Gut 60:1563–1571CrossRef Fitzmaurice K, Petrovic D, Ramamurthy N et al (2011) Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection. Gut 60:1563–1571CrossRef
Metadaten
Titel
Complete genome sequencing and evolutionary analysis of hepatitis C virus subtype 6a, including strains from Guangdong Province, China
verfasst von
Ru Xu
Hao Wang
Jieting Huang
Min Wang
Qiao Liao
Zhengang Shan
Huishan Zhong
Xia Rong
Yongshui Fu
Publikationsdatum
20.01.2022
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 2/2022
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-021-05358-7

Weitere Artikel der Ausgabe 2/2022

Archives of Virology 2/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.